“…Paf-acether (Paf, formerly platelet-activating factor; Benveniste et al, 1972), identified as being 1-0-hexa/ octadecyl-2-acetyl-sn-3-glycero-phosphocholine, is a potent mediator of inflammation, which induces bronchoconstriction and airway hyperreactivity in several animal species including man (Chung et al, 1986;Cuss et al, 1986;Anderson et al, 1988). However, in vitro, this phosphoetherlipid does not contract bronchial and tracheal preparations from different species (Cerrina et al, 1983;Stimler & O'Flaherty, 1983) and paradoxically relaxes resting guinea-pig tracheal preparations (Prancan et al, 1982).…”